Back to drug

The Drug-Induced Respiratory Disease Website

Can be acute or subacute in onset. Severity is from the asymptomatic/subclinical state to overt heart failure. May cause acute or chronic left ventricular dysfunction, congestive heart failure (XIIIa) or cardiogenic pulmonary edema (IId). In some cases, will improve with drug stoppage

Publications

Lee SH, Kim YS

Reversible dilated cardiomyopathy associated with long-term anagrelide therapy in a patient with chronic myeloproliferative disease: a serial 2-dimensional speckle tracking echocardiographic study.

International journal of cardiology 2014 May 15;173;e45-6 — 2014 May 15 — e45-6

James CW

Anagrelide-induced cardiomyopathy.

Pharmacotherapy 2000 Oct;20;1224-7 — 2000 Oct — 1224-7